• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Dermatofibrosarcoma

Dermatofibrosarcoma - 15 Studies Found

Completed : Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
: Dermatofibrosarcoma
: 2005-07-20
: Drug: Imatinib (Glivec)
Completed : Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
: Dermatofibrosarcoma Protuberans
: 2005-10-20
: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days
Terminated : Phase II Pazopanib Study in Advanced Dermatofibrosarcomas
: Dermatofibrosarcomas of DARIER FERRAND(DFSP)
: 2010-01-28
: Drug: Pazopanib Administration of pazopanib per os 800mg/ qd during 6 months until stable response accor
Completed : Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
:
  • Adult Fibrosarcoma
  • Dermatofibrosarcoma Protuberans
  • : 2004-06-10
    :
    • Drug: imatinib mesylate Given

Completed : Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
: Soft Tissue Neoplasms
: 2005-09-12
Completed : Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
: Sarcoma
: 2004-06-10
:
  • Drug: imatinib mesylate
  • Procedure: convent

Completed : Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
:
  • Hypereosinophilic Syndrome
  • Systemic Mastocytosis
  • Chronic M
    : 2005-09-13
    : Drug: imatinib mesylate Other Name: STI571
Completed : Spanish Registry of Mohs Surgery
:
  • Skin Neoplasms
  • Carcinoma, Basal Cell
  • Carcinoma, Squamous C
    : 2014-12-01
    : Procedure: Mohs surgery A surgical technique used primarily in the treatment of skin neoplasms, especial
Completed : To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
:
  • Neuroblastoma
  • Rhabdomyosarcoma
  • Ewing's Sarcoma
  • : 2013-09-27
    : Drug: nab-paclitaxel nab-paclitaxel 100-240 mg/m2 IV on Days 1, 8 and 15 of a 28-day cycle
Completed : AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
:
  • Adult Fibrosarcoma
  • Adult Leiomyosarcoma
  • Adult Liposarcoma<
    : 2008-04-15
    : Drug: saracatinib Given orally Other Name: AZD0530
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.